All Stories

  1. Global, regional, and national burden of injuries, and burden attributable to injuries risk factors, 1990 to 2019: results from the Global Burden of Disease study 2019
  2. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
  3. Population-Level Distribution, Risk Factors, and Burden of Mortality and Disability-Adjusted Life Years Attributable to Major Noncommunicable Diseases in Western Europe (1990-2021): Ecological Analysis
  4. Psychometric Properties and Measurement Equivalence of the Workplace Incivility Scale Across Cultures: Insights from Daily Diary Study
  5. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  6. Comparative Effectiveness of Anti-Hyperlipidemic Drugs Monotherapy in Primary Prevention of Cardiovascular Disease
  7. Comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events—a real-world longitudinal inception cohort study
  8. Epidemiology and demographic patterns of cardiovascular diseases and neoplasms deaths in Western Europe: a 1990–2019 analysis
  9. Epidemiological trends and age-period-cohort effects on cardiovascular diseases burden attributable to ambient air pollution across BRICS
  10. Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis
  11. Burden of disease scenarios for 204 countries
  12. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  13. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  14. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a syst...
  15. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  16. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  17. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  18. Estimating disparities of prostate cancer burden and its attributable risk factors for males across the BRICS‐plus, 1990–2019: A comparable study of key nations with emerging economies
  19. Does supervisor mistreatment lead to subordinates’ incivility at work? Evidence from a cross-cultural daily diary
  20. Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study
  21. The adverse effect of gestational diabetes mellitus and hypertensive disorders of pregnancy on maternal–perinatal outcomes among singleton and twin pregnancies: a retrospective cohort study (2011–2019)
  22. Global, regional, and national mortality due to unintentional carbon monoxide poisoning, 2000–2021: results from the Global Burden of Disease Study 2021
  23. The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories
  24. Estimating disparities in breast cancer screening programs towards mortality, case fatality, and DALYs across BRICS-plus
  25. Epidemiological Trends in Cardiovascular Disease Mortality Attributable to Modifiable Risk Factors and Its Association with Sociodemographic Transitions across BRICS-Plus Countries
  26. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  27. Epidemiological Trends in Cardiovascular Disease Mortality Attributable to Modifiable Risk Factors and Its Association with Sociodemographic Transition across BRICS-Plus
  28. Risk assessment of dietary factors in global pattern of ischemic heart disease mortality and disability-adjusted life years over 30 years
  29. Epidemiological trend and age-period-cohort effects on cardiovascular disease mortality and disability-adjusted life years attributable to dietary risks and high body mass index at the regional and country level across China and Pakistan
  30. A moderated mediation model between perceived incivility and instigated incivility on workplace: A cross-cultural daily diary study.
  31. Breast cancer epidemiology and sociodemographic differences in BRICS-plus countries from 1990 to 2019: An age period cohort analysis
  32. A Mediation Moderation Model between Self-Evaluative Emotions and Relapse Rate among Polysubstance Users: A Comparative Cross-Sectional Study
  33. Evaluation of Lee–Carter model to breast cancer mortality prediction in China and Pakistan
  34. More recent insights into the breast cancer burden across BRICS-Plus: Health consequences in key nations with emerging economies using the global burden of disease study 2019
  35. The temporal trend of disease burden attributable to metabolic risk factors in China, 1990–2019: An analysis of the Global Burden of Disease study
  36. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018
  37. Mixed exposure to phenol, parabens, pesticides, and phthalates and insulin resistance in NHANES: A mixture approach
  38. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  39. Time trends in tuberculosis mortality across the BRICS: an age-period-cohort analysis for the GBD 2019
  40. Shame and guilt activations: Associations and sociodemographic differences among ploysubstance abusers
  41. Prediction of cardiovascular diseases mortality- and disability-adjusted life-years attributed to modifiable dietary risk factors from 1990 to 2030 among East Asian countries and the world
  42. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  43. Eliciting national and subnational sets of disability weights in mainland China: Findings from the Chinese disability weight measurement study
  44. An efficient application of scrambled response approach to estimate the population mean of the sensitive variables
  45. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
  46. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019
  47. Combined exposure to multiple metals on serum uric acid in NHANES under three statistical models
  48. Type-2 Diabetes Mellitus (T2DM): Spatial-temporal Patterns of Incidence, Mortality and Attributable Risk Factors from 1990 to 2019 among 21 World Regions
  49. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
  50. The trend in delayed childbearing and its potential consequences on pregnancy outcomes: a single center 9-years retrospective cohort study in Hubei, China
  51. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019
  52. Correction to: Demographics of road injuries and micromobility injuries among China, India, Japan, and the United States population: evidence from an age-period-cohort analysis
  53. Association of Serum 25(OH)D, Cadmium, CRP With All-Cause, Cause-Specific Mortality: A Prospective Cohort Study
  54. Demographics of road injuries and micromobility injuries among China, India, Japan, and the United States population: evidence from an age-period-cohort analysis
  55. Lifestyle and Socioeconomic Transition and Health Consequences of Breast Cancer in the East Asia Region, From 1990 to 2019
  56. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  57. Changes in adverse pregnancy outcomes in women with advanced maternal age (AMA) after the enactment of China’s universal two-child policy
  58. Breast Cancer Mortality Trends and Predictions to 2030 and Its Attributable Risk Factors in East and South Asian Countries
  59. Age–Period–Cohort Analysis of Long Trend of Mortality for Stroke and Subtypes Attributed to High SBP in Chinese Adults
  60. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
  61. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  62. Long-Term Changes of HIV/AIDS Incidence Rate in China and the U.S. Population From 1994 to 2019: A Join-Point and Age-Period-Cohort Analysis
  63. Lung Cancer Death Attributable to Long-Term Ambient Particulate Matter (PM2.5) Exposure in East Asian Countries During 1990–2019
  64. Global, regional, and national sex-specific burden and control of the HIV epidemic
  65. Global Burden of Ischemic Heart Disease and Attributable Risk Factors, 1990–2017: A Secondary Analysis Based on the Global Burden of Disease Study 2017
  66. Long-term trends of tuberculosis incidence and mortality in four central African countries
  67. Characterization and influencing factors of the pig movement network in Hunan Province, China
  68. Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis
  69. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  70. Correction to: Evaluation of lifestyle risk factor differences in global patterns of breast cancer mortality and DALYs during 1990–2017 using hierarchical age-period-cohort analysis
  71. The comparison of epidemiological characteristics between confirmed and clinically diagnosed cases with COVID-19 during the early epidemic in Wuhan, China
  72. The Association of Hypertension With the Severity of and Mortality From the COVID-19 in the Early Stage of the Epidemic in Wuhan, China: A Multicenter Retrospective Cohort Study
  73. Evaluation of lifestyle risk factor differences in global patterns of breast cancer mortality and DALYs during 1990–2017 using hierarchical age-period-cohort analysis
  74. Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  75. Trend dynamics of thyroid cancer incidence among China and the U.S. adult population from 1990 to 2017: a joinpoint and age-period-cohort analysis
  76. The Trend of HIV/AIDS Incidence and Risks Associated with Age, Period, and Birth Cohort in Four Central African Countries
  77. Statistical analysis of COVID-19 infection caused by environmental factors: Evidence from Pakistan
  78. DIAGNOSTIC ACCURACY OF DRUG SCREENING IMMUNOASSAYS IN DRUG FACILITATED CRIMES
  79. Corrigendum to: Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: evidence from a retrospective, observational study
  80. Effect of preeclampsia and premature rupture of membrane on neonatal birth weight and length by gestational age: A retrospective study in China
  81. The Comparison of Epidemiological Characteristics Between Confirmed and Clinically Diagnosed Cases With COVID-19 in Wuhan, China
  82. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
  83. A multi-country comparison of stochastic models of breast cancer mortality with P-splines smoothing approach
  84. Correction to: The epidemiological characteristics of deaths with COVID-19 in the early stage of epidemic in Wuhan, China
  85. The epidemiological characteristics of deaths with COVID-19 in the early stage of epidemic in Wuhan, China
  86. Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: evidence from a retrospective observational study
  87. Use of ATR-FTIR for detection ofSalmonella typhiinfection in human blood sera
  88. Trend Dynamics of Thyroid Cancer Incidence among China and the U.S. Adult Population from 1992-2017: A Join-point and Age-Period-Cohort
  89. The mortality of lung cancer attributable to smoking among adults in China and the United States during 1990–2017
  90. Correlation of MSH2 exonic deletions and protein downregulation with breast cancer biomarkers and outcome in Pakistani women/patients
  91. Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2)
  92. Trend Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in 16 Cities of Hubei Province, China
  93. Secular Trend of Cancer Death and Incidence in 29 Cancer Groups in China, 1990–2017: A Joinpoint and Age–Period–Cohort Analysis
  94. XPC as breast cancer susceptibility gene: evidence from genetic profiling, statistical inferences and protein structural analysis
  95. Age-period-cohort analysis of kidney cancer deaths attributable to high body-mass index in China and U.S. adults
  96. Trends and Projections in Breast Cancer Mortality among four Asian countries (1990–2017): Evidence from five Stochastic Mortality Models
  97. A Hierarchical Age–Period–Cohort Analysis of Breast Cancer Mortality and Disability Adjusted Life Years (1990–2015) Attributable to Modified Risk Factors among Chinese Women
  98. An Updated Trend Analysis Representing the Outbreak of Novel Coronavirus (2019-nCoV) in 16 Cities of Hubei Province, China Using Logistic S-Curve Model
  99. Ischemic Heart Disease Burden and Attributable  Risk Factors in 195 Countries and Territories, 1990-2017: Results from the Global Burden of Disease Study 2017
  100. Correlation of MLH1 polymorphisms, survival statistics, in silico assessment and gene downregulation with clinical outcomes among breast cancer cases
  101. FTIR spectroscopy of freeze-dried human sera as a novel approach for dengue diagnosis
  102. Recent insights into breast cancer incidence trends among four Asian countries using age-period-cohort model
  103. Long-Term Trends of Liver Cancer Incidence and Mortality in China 1990–2017: A Joinpoint and Age–Period–Cohort Analysis
  104. An insight into clinical outcome of XPG polymorphisms in breast cancer